1.
CAR T cell immunotherapy for human cancer.
by June, Carl H
March 23, 2018
Science (New York, N.Y.), Vol.359(6382), pp.1361-1365
2018
2.
Overcoming resistance to checkpoint blockade therapy by targeting PI3K[gamma] in myeloid cells
by De Henau, Olivier
Nature, Nov 17, 2016, Vol.539(7629), pp.443-447K
3.
Patrolling monocytes control tumor metastasis to the lung.
by Hanna, Richard N
Science (New York, N.Y.), November 20, 2015, Vol.350(6263), pp.985-990
4.
Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors.(Report)
by Kang, Sunghyun
Bioorganic & Medicinal Chemistry Letters, March 15, 2013, Vol.23(6), p.1748(4)
5.
Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy
by Schmid, Johannes
Journal of Allergy and Clinical Immunology, Sep 2014, Vol.134(3), pp.741-744.e5
6.
Subcutaneous immunotherapy
by Nelson, Harold
Journal of Allergy and Clinical Immunology, Oct 2011, Vol.128(4), pp.907-907
7.
Sublingual immunotherapy in southern Africa: Lessons learned
by Potter, Paul
The Journal of Allergy and Clinical Immunology, July 2013, Vol.132(1), pp.99-100
8.
"Transflammation": When Innate Immunity Meets Induced Pluripotency.(Report)
by O'neill, Luke A. J.
Cell, Oct 26, 2012, Vol.151(3), p.471(3)
9.
Erratum to: A Nebulized Gelatin Nanoparticle-Based CpG Formulation is Effective in Immunotherapy of Allergic Horses.(Correction notice)
by Klier, John
Pharmaceutical Research, July, 2012, Vol.29(7), p.2030(1)
10.
Immunotherapy and the concept of a clinical cure
by Eggermont, Alexander M.M
European Journal of Cancer, September 2013, Vol.49(14), pp.2965-2967
11.
Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies
by Maletzki, Claudia
European Journal of Cancer, July, 2013, Vol.49(11), p.2587(9)
12.
Strongyloidiasis complicating immunosuppression for pemphigus vulgaris.(Report)
by Walker, S. L.
British Journal of Dermatology, Dec, 2013, Vol.169(6), p.1363(2)
13.
Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.(Report)
by Reenaers, C.
Alimentary Pharmacology and Therapeutics, April, 2013, Vol.37(7), p.752(2)
14.
Early Post-transplant Lymphoproliferative Disease in the Donor Ureter Without Systemic Involvement: A Case Report
by Bennett, W.M.
Transplantation Proceedings, 2015, Vol.47(7), p.2301(3)
15.
Intestinal and Multivisceral Transplantation Immunosuppression Protocols -- Literature Review.(Report)
by Trevizol, A. P.
Transplantation Proceedings, Oct, 2012, Vol.44(8), p.2445(4)
16.
Vascularized Anal Autotransplantation Model in Rats: Preliminary Report.(Report)
by Araki, J.
Transplantation Proceedings, Nov, 2011, Vol.43(9), p.3552(5)
17.
Haemophagocytic lymphohistiocytosis in a patient with severe burns
by Porter, J. R. S.
Anaesthesia, April, 2013, Vol.68(4), p.413(4)
18.
A case of fully recovered giant cell myocarditis treated with immunosuppression therapy
by Ashikaga, Kohei
International Journal of Cardiology, Sept 1, 2013, Vol.167(5), p.e149-e151
19.
CANCER IMMUNOLOGY. The "cancer immunogram".
by Blank, Christian U
Science (New York, N.Y.), May 6, 2016, Vol.352(6286), pp.658-660
20.
Cancer immunotherapy using checkpoint blockade.
by Ribas, Antoni
March 23, 2018
Science (New York, N.Y.), Vol.359(6382), pp.1350-1355
2018
